News

• 

   08.06.2026

  Drug-resistant tuberculosis threatens children in low- and middle-income countries

  A comprehensive global analysis reveals a marked increase in drug-resistant tuberculosis (DR-TB) among children. Girls in particular face a higher risk of death—highlighting significant gaps in diagnosis, treatment, and equitable access to healthcare.

• 

   05.06.2026

  TBnet Academy 2026 in Vilnius

  In the year marking the 20th anniversary of the Tuberculosis Network European Trials Group, TBnet successfully held its 12th TBnet Academy from 31 May to 3 June 2026 in Vilnius, Lithuania. The Academy once again brought together 20 outstanding young scholars from across Europe working in translational science, microbiology and clinical medicine in the fields of tuberculosis and diseases caused by non-tuberculous mycobacteria.

• 

   03.06.2026

  Funding approved for innovative microfluidics project

  The research group ‘Biophysics’ at the Research Center Borstel, Leibniz Lung Center (FZB) has some great news to celebrate: Last week, the “Leibniz Health Technologies” research network approved a feasibility study proposed by Dr Christian Nehls (FZB) in collaboration with Dr Anja Silge (Leibniz Institute of Photonics, IPHT) and Prof Miriam Agler-Rosenbaum (Leibniz Institute for Natural Product Research and Infection Biology, HKI).